Teva Pharmaceutical Inds

ISIN US8816242098

 | 

WKN 883035

Marktkapitalisatie (in EUR)
29,805 m
Land
Israel
Sector
Healthcare
Dividendrendement
0.00%
 

Overzicht

Koers

Beschrijving

Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: United States, Europe, and International Markets. The United States segment focuses on therapeutic area of central nervous system (CNS) portfolio, and is involved in the distribution business of generic, biosimilar and medicines, and over-the-counter (OTC) pharmaceutical products from the firm and third-party manufacturers to independent retail pharmacies, pharmacy retail chains, hospitals, and physician offices in the United States. The Europe segment offers OTC portfolio including SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brands in European Union, the United Kingdom, and certain other European countries. The International Markets segment provides its products to countries such as Canada, Israel, Russia, Latin America, and Japan. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.
Toon meer Toon minder
Healthcare Biopharmaceuticals Other Biopharmaceuticals Israel

Grafiek

Financiële kerngegevens

Kerncijfers

Marktkapitalisatie, EUR 29,805 m
WPA, EUR 1.08
KBV 4.4
K/W 24.6
Dividendrendement 0.00%

Winst- en verliesrekening (2025)

Omzet, EUR 15,477 m
Netto-inkomen, EUR 1,260 m
Winstmarge 8.14%

In welke ETF zit Teva Pharmaceutical Inds?

Er zijn 21 ETF's die Teva Pharmaceutical Inds bevatten. Al deze ETF's staan in de tabel hieronder. De ETF met de grootste weging van Teva Pharmaceutical Inds is de iShares Edge MSCI World Value Factor UCITS ETF USD (Dist).
ETF Weging Investeringsfocus Fondsgrootte (in m EUR)
UBS Core MSCI World UCITS ETF USD acc 0.04%
Aandelen
Wereld
7.056
iShares MSCI World UCITS ETF (Dist) 0.04%
Aandelen
Wereld
7.117
Vanguard LifeStrategy 80% Equity UCITS ETF (EUR) Accumulating 0.00%
Aandelen
Wereld
Multi-assetstrategie
934
iShares MSCI World Health Care Sector Advanced UCITS ETF USD (Dist) 0.12%
Aandelen
Wereld
Gezondheidszorg
Sociaal/Milieu
513
Vanguard LifeStrategy 20% Equity UCITS ETF Distributing 0.00%
Aandelen
Wereld
Multi-assetstrategie
14
iShares MSCI ACWI UCITS ETF USD (Acc) 0.04%
Aandelen
Wereld
22.725
Vanguard LifeStrategy 80% Equity UCITS ETF Distributing 0.00%
Aandelen
Wereld
Multi-assetstrategie
69
iShares Edge MSCI World Value Factor UCITS ETF USD (Dist) 0.26%
Aandelen
Wereld
Waarde
270
Vanguard LifeStrategy 40% Equity UCITS ETF Accumulating 0.00%
Aandelen
Wereld
Multi-assetstrategie
207
Vanguard LifeStrategy 60% Equity UCITS ETF Accumulating 0.00%
Aandelen
Wereld
Multi-assetstrategie
727
UBS Core MSCI World UCITS ETF hEUR acc 0.04%
Aandelen
Wereld
508
Xtrackers MSCI World UCITS ETF 1D 0.04%
Aandelen
Wereld
4.109
Vanguard FTSE All-World UCITS ETF (USD) Accumulating 0.00%
Aandelen
Wereld
31.452
iShares MSCI World ESG Enhanced CTB UCITS ETF USD (Dist) 0.01%
Aandelen
Wereld
Sociaal/Milieu
697
UBS Core MSCI World UCITS ETF USD dis 0.04%
Aandelen
Wereld
1.352
iShares MSCI World Screened UCITS ETF USD (Dist) 0.05%
Aandelen
Wereld
Sociaal/Milieu
979
UBS Core MSCI World UCITS ETF hGBP dis 0.04%
Aandelen
Wereld
88
Vanguard LifeStrategy 40% Equity UCITS ETF Distributing 0.00%
Aandelen
Wereld
Multi-assetstrategie
36
Vanguard LifeStrategy 60% Equity UCITS ETF Distributing 0.00%
Aandelen
Wereld
Multi-assetstrategie
92
Vanguard FTSE All-World UCITS ETF (USD) Distributing 0.00%
Aandelen
Wereld
19.088
Vanguard LifeStrategy 20% Equity UCITS ETF Accumulating 0.00%
Aandelen
Wereld
Multi-assetstrategie
94

Prestaties

Rendementsoverzicht

YTD -3,36%
1 maand -10,55%
3 maanden -2,08%
6 maanden +50,90%
1 jaar +85,57%
3 jaar +217,57%
5 jaar +165,13%
Since inception -49,77%
2025 +24,42%
2024 +130,93%
2023 +7,26%
2022 +16,51%

Maandelijks rendement in een heat map

Risico

Risk metrics in this section:
 
  • Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
  • Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
  • Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.
ETF-rendementen zijn inclusief dividenduitkeringen (indien van toepassing).
Toon meer Toon minder

Risico-overzicht

Volatiliteit 1 jaar 41,87%
Volatiliteit 3 jaar 41,01%
Volatiliteit 5 jaar 41,46%
Rendement/Risico 1 jaar 2,04
Rendement/Risico 3 jaar 1,14
Rendement/Risico 5 jaar 0,52
Maximaal waardedaling 1 jaar -19,38%
Maximaal waardedaling 3 jaar -47,37%
Maximaal waardedaling 5 jaar -47,37%
Maximaal waardedaling sinds aanvang -91,56%

Voortschrijdende volatiliteit over 1 jaar

— Gegevens verstrekt door Trackinsight, etfinfo, Xignite Inc., gettex, FactSet en justETF GmbH.

Standaard zijn ETF-rendementen inclusief dividenduitkeringen (indien van toepassing). Er is geen garantie voor de volledigheid, juistheid en correctheid van de getoonde informatie.